CO - Global Cord Blood Corporation

NYSE - NYSE Delayed Price. Currency in USD
5.35
-0.42 (-7.28%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close5.77
Open6.00
Bid5.50 x 1000
Ask0.00 x 1800
Day's Range4.82 - 6.03
52 Week Range4.82 - 10.12
Volume148,843
Avg. Volume48,734
Market Cap650.298M
Beta (3Y Monthly)0.31
PE Ratio (TTM)18.26
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.08 (1.39%)
Ex-Dividend Date2018-07-31
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • ACCESSWIREyesterday

    Global Cord Blood Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / June 19, 2019 / Global Cord Blood Corp. (NYSE: CO ) will be discussing their earnings results in their 2019 Fourth Quarter Earnings to be held on June 19, 2019 at 8:00 AM Eastern ...

  • PR Newswire2 days ago

    Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019

    Added 22,194 New Subscribers in 4Q19 4Q19 Revenues Increased by 8.0% YoY to RMB251.7 Million ( $37.5 Million ) 4Q19 Operating Income Increased to RMB 88.9 Million ($ 13.2 Million) Conference Call to be ...

  • PR Newswire2 days ago

    Shareholder of Global Cord Blood Corporation (NYSE: CO) Hires Global Law Firm, The Seiden Group, to Help Investigate and Enforce Rights

    NEW YORK, June 17, 2019 /PRNewswire/ -- A shareholder of Global Cord Blood Corporation (CO) (the "Company" or "Global Cord") has hired The Seiden Group, a law firm headquartered in New York, as shareholder counsel to communicate minority shareholder interests to the Independent Directors and help effect necessary changes for the benefit of the Company and its shareholders, including minority shareholders in the United States. The Seiden Group issued a letter today to the Independent Directors of Global Cord on behalf of the shareholder making certain requests relating to a potential merger with a Singaporean company and explaining why the deal would harm investors.

  • PR Newswire9 days ago

    Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results

    Earnings Call Scheduled for 8:00 a.m. ET on June 19, 2019 HONG KONG , June 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release ...

  • PR Newswire14 days ago

    Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

    HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal letter dated June 4, 2019 received by the Company's Board of Directors (the "Board") from Cordlife Group Limited ("Cordlife"), a company listed on the Mainboard of the Singapore Exchange Securities Trading Limited ("SGX"), pursuant to which Cordlife proposes to combine the businesses of Cordlife and the Company by way of a statutory merger, the Board has formed a special committee of independent directors who are not affiliated with Cordlife (the "Special Committee") to evaluate such proposal. The Special Committee consists of Mr. Mark D. Chen, Dr. Ken Lu and Ms. Jennifer J. Weng, each of whom currently serves as an independent director on the Board, with Mr. Chen serving as the chair of the Special Committee.

  • PR Newswire16 days ago

    Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company

    HONG KONG, June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has received a non-binding proposal letter from Cordlife Group Limited ("Cordlife"), a company listed on the Mainboard of the Singapore Exchange Securities Trading Limited ("SGX"), pursuant to which Cordlife proposes to combine the businesses of Cordlife and the Company, by way of a statutory merger.

  • ASICS And ASICS RUNKEEPER™ Celebrate The Love Of The Run For Global Running Day
    PR Newswire17 days ago

    ASICS And ASICS RUNKEEPER™ Celebrate The Love Of The Run For Global Running Day

    ASICS and ASICS RUNKEEPER community to share the ups (and downs) we've had with our shoes with #DearShoes social media giveaway, in-app run challenge and nearly 50 in-store events across the U.S. BOSTON, June 3, 2019 /PRNewswire/ -- ASICS, the true sport performance brand, and ASICS Runkeeper™ app are celebrating Global Running Day in the United States with a nationwide activation that gives runners and run lovers a platform to share why they love the pastime. With a deep history rooted in running, ASICS is at the core of many stories that describe the passion behind a run.

  • PR Newswire3 months ago

    Global Cord Blood Corporation Raised Subscription Fee

    HONG KONG, April 1, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company is increasing its processing fee by RMB3,000 to RMB9,800, effective on April 1, 2019. The Company's annual storage fee is unaffected by this increase. The Company is committed to delivering high quality and top of the line services to all clients, and this is evidenced by the Company's continuous investment in cord blood banking hardware as well as software.

  • PR Newswire4 months ago

    Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019

    3Q 19 Added 23,663 New Subscribers Revenues Up 3.7% YoY to RMB254.2 Million ( $37.0 Million )  Operating   Income Increased to RMB92.6 Million ( $13.5 Million ) Conference Call to be Held on February 26, ...

  • PR Newswire4 months ago

    Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results

    Earnings Call Scheduled for 8:00 a.m. ET on February 26, 2019 HONG KONG , Feb. 19, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord ...

  • PR Newswire6 months ago

    Global Cord Blood Corporation Announces Results of 2018 Annual General Meeting

    HONG KONG , Dec. 6, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic ...

  • PR Newswire7 months ago

    Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2019

      2Q19 Added 22,908 New Subscribers Revenues Up 5.3% YoY to RMB247.1 Million ( $36.0 Million )                                    Operating   Income Up 37.3% YoY to RMB104.8 Million ( $15.3 Million )   ...

  • PR Newswire7 months ago

    Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2019 Financial Results

    Earnings Call Scheduled for 8:00 a.m. ET on November 28 , 2018 HONG KONG , Nov. 20, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of ...

  • PR Newswire9 months ago

    Global Cord Blood Corporation to Hold Annual General Meeting of Shareholders in Hong Kong on December 5, 2018

    HONG KONG, Sept. 21, 2018 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2018 annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 5, 2018 (8:00 a.m. U.S. Eastern Standard Time on December 5, 2018).